Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after ...

President Trump and his health secretary, Robert F. Kennedy Jr., on Monday announced that the administration is exploring ...

Artificial intelligence has danced around the fringes of prostate cancer for years, but in 2024, it got a profile-raising ...

In a Q&A with STAT, Nobel winner Drew Weissman addressed concerns raised about Covid shots at a recent meeting of federal ...

Today, we read about a big acquisition fueled by obesity, doctors shifting their views on biopharma marketing, see a ...

Trump administration officials are discussing creating a website, perhaps branded TrumpRx, to sell prescription drugs at a ...

President Trump’s attempts to cover bruises on his hand with makeup have garnered national attention in recent weeks, even ...

Pfizer has struggled to develop an obesity drug. It's now buying biotech Metsera in a $4.9B deal, giving it a range of ...

An MBX drug showed efficacy in treating chronic hypoparathyroidism, but the study raised questions about its competitive ...

The largest professional organization representing ENT doctors in the U.S. has endorsed gun silencers, a scientifically flawed policy blunder.

To avoid fines for reporting excessive hospital-acquired infections, some facilities are discouraging testing.

Gordon Guyatt, a co-author of systematic reviews of gender-affirming care, calls use of the findings to justify banning care ...